Arslan Hamid (@hamidarslan_) 's Twitter Profile
Arslan Hamid

@hamidarslan_

Doctoral Candidate, Immunology-Metabolism-Metaflammation. @LIMES_Bonn @UniBonn

ID: 821441784

calendar_today13-09-2012 12:42:23

97 Tweet

172 Takipçi

997 Takip Edilen

News from Science (@newsfromscience) 's Twitter Profile Photo

There’s a new call from the White House to develop vaccines that might protect against future #SARSCoV2 mutants or even unknown coronaviruses—but the scientific, logistical, and regulatory hurdles for any next-generation vaccines are high. fcld.ly/o9a7d2s

New Scientist (@newscientist) 's Twitter Profile Photo

Determining the structure of a single protein used to take many years. Now biologists can look at the structure of almost any known protein in minutes newscientist.com/article/233147…

Scientific American (@sciam) 's Twitter Profile Photo

DeepMind’s system for predicting the 3D structure of proteins is among five recipients of science’s most lucrative awards bit.ly/3VXTcnU

Nature Portfolio (@natureportfolio) 's Twitter Profile Photo

A Review in Nature Immunology is an introduction for immunologists with no experience in the field of omics but with the intention to learn about and apply these approaches, and for immunologists who want to make the most of interdisciplinary networks. go.nature.com/3yO6Hwb

A Review in <a href="/NatImmunol/">Nature Immunology</a> is an introduction for immunologists with no experience in the field of omics but with the intention to learn about and apply these approaches, and for immunologists who want to make the most of interdisciplinary networks. go.nature.com/3yO6Hwb
Science Magazine (@sciencemagazine) 's Twitter Profile Photo

New in Science: Researchers have determined the cryo–electron microscopy structure of the hepatitis C virus E1E2 glycoprotein complex. The structure provides a blueprint for the design of vaccines and drugs that target the virus. scim.ag/jP

Science Magazine (@sciencemagazine) 's Twitter Profile Photo

New in Science Translational Medicine: A machine learning system stratifies patients with #sepsis and other infections by profiling blood gene expression and immune function—giving a tool to inform clinical decision-making. scim.ag/wV

New in <a href="/ScienceTM/">Science Translational Medicine</a>: A machine learning system stratifies patients with #sepsis and other infections by profiling blood gene expression and immune function—giving a tool to inform clinical decision-making. scim.ag/wV
The Wall Street Journal (@wsj) 's Twitter Profile Photo

Elon Musk’s neuroscience startup Neuralink showcased ‘telepathic typing’ through a monkey with a brain implant, and said that the technology should be ready for human testing in 6 months #WSJWhatsNow on.wsj.com/3irryQX

Science Magazine (@sciencemagazine) 's Twitter Profile Photo

A new era of biological engineering is emerging in which living cells are used as building blocks to address therapeutic challenges. Read more in this #ScienceReview: scim.ag/11h

A new era of biological engineering is emerging in which living cells are used as building blocks to address therapeutic challenges. 

Read more in this #ScienceReview: scim.ag/11h
Neuralink (@neuralink) 's Twitter Profile Photo

We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study! This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our

Arslan Hamid (@hamidarslan_) 's Twitter Profile Photo

🔬 Our research in Cancer Cell International explores PRKCG SNPs in hepatocellular carcinoma. We delved into identifying a potential genetic marker for HCC. This could pave the way for improved diagnosis and therapy. cancerci.biomedcentral.com/articles/10.11… #Genetics #Oncology

CORONARY CONNECT (@coronaryconnect) 's Twitter Profile Photo

What’s new in lipid management? Cardiologists Dr Robert Giugliano & Prof. Ulrich Laufs share expert insights on recent data in lipid management from AHA 2025 📺 They review data from VESALIUS-CV, VESALIUS-REAL, CORE-TIMI 72a/CORE2-TIMI 72b trials, and trials investigating CTX310